相关实验视频

Updated: Jun 30, 2025

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

在治疗严重静脉血栓栓塞的模式转变

Fábio Henrique Rossi¹, Francisco José Osse¹, Patricia Ellen Thorpe¹

¹Instituto de Excelência em Doenças Venosas - IEDV, São Paulo, SP, Brasil.

Jornal vascular brasileiro

|March 15, 2024

概括

肺栓塞 (PE) 和深静脉血栓塞 (DVT) 是主要的死亡原因. 一个新的静脉血栓栓塞瘤应对小组 (VTERT®) 方法扩大了现有的肺栓塞瘤应对小组 (PERT®),包括严重的DVT,旨在减少死亡率和并发症.

科学领域:

心血管医学心血管医学
血管外科血管外科
紧急医疗紧急医疗

背景情况:

肺栓塞 (PE) 是心血管死亡的主要原因和可预防的住院死亡率.
深静脉血栓 (DVT) 是PE的主要原因,并导致显著的长期并发症.
目前的肺栓塞反应小组 (PERT®) 协议侧重于PE,而不是严重的DVT.

研究的目的:

为静脉血栓栓塞 (VTE) 提出一个扩展的快速反应概念.
将严重深静脉血栓塞 (DVT) 的管理整合到一个多学科的快速反应框架中.
减少与VTE相关的直接风险和长期后果.

主要方法:

审查目前的PE和DVT管理策略.
对VTE的新的皮穿式和机械血栓切除技术的评估.
为新的静脉血栓栓塞反应小组 (VTERT®) 模型提出建议.

主要成果:

严重的 iliofemoral DVT 需要积极的管理,以防止 PE 和减少后续.
穿皮技术和机械血栓切除术在静脉瘤治疗中显示出有前途的结果.
对于PE和严重的DVT,一个集成的快速响应系统是可行的.

结论:

拟议的静脉血栓栓塞反应小组 (VTERT®) 模型可以改善PE和严重DVT的结果.
将PERT®概念扩展到包括DVT解决了VTE护理中的一个关键差距.
多学科,快速干预是有效管理复杂VTE病例的关键.

关键词:

深静脉血栓形成的原因是深静脉血栓形成.机械血栓溶解是一种机械血栓溶解.这是一个多学科的多学科教育.肺栓塞肺栓塞是一种肺栓塞.进行血栓切除术 (thrombectomy).静脉血栓塞栓症是一种静脉血栓塞栓.

更多相关视频

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins

Published on: May 24, 2024

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

相关概念视频

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Esophageal Varices-II: Clinical Features and Management

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...